ArticleFrontiers in endocrinology2023

Editorial: Genome editing applications of CRISPR/Cas9 in metabolic diseases, hormonal system and cancer research.

Pengpeng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.